Skip to main content

Supernus Pharmaceuticals, Inc.

SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001356576

No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Supernus Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Supernus Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Supernus Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Khattar Jack A.President, CEO1,258,351Aug 14, 202612
Rubin JonathanSVP, Chief Medical Officer13,979Aug 14, 20265
Bhatt Padmanabh P.Sr. VP of IP, CSO18,637Aug 14, 20268
Mottola FrankSVP, Chief Tech. Ops. Officer19,544Aug 14, 20268
Dec Timothy CSenior Vice-President & CFO9,129Aug 14, 20267
Hudson Frederick M.Director60,413Mar 16, 20264
Horich William ToddSVP, Commercial Operations0Mar 10, 20261
Gemayel GeorgesDirector27,277Mar 9, 20263
Newhall Charles W IIIDirector124,119Feb 25, 20264
Barlow CarroleeDirector27,045Feb 25, 20262
Sensenig BethanyDirector0Feb 23, 20262
Siebert John MDirector87,943Feb 27, 20240
Martin Tami TillotsonSr. V.P., Regulatory Affairs86,933Feb 27, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 18, 2025 (view filing)Aug 144 daysSensenig BethanyDirectorSSale−5.37K$42.25−$226.8K−100.0%0 after10b5-1
Aug 26, 2025 (view filing)Aug 224 daysNewhall Charles W IIIDirectorSSale−1.41K$45.00−$63.5K−1.0%134.2K after10b5-1
Aug 26, 2025 (view filing)Aug 224 daysDec Timothy CSenior Vice-President & CFOSSale−11.8K$44.49−$524.1K−90.4%1.25K after
Aug 26, 2025 (view filing)Aug 224 daysKhattar Jack A.President, CEOSSale−1.50K$45.00−$67.5K−0.1%1.07M after10b5-1
Aug 27, 2025 (view filing)Aug 252 daysNewhall Charles W IIIDirectorSSale−1.00K$45.00−$45.0K−0.7%133.2K after10b5-1
Aug 27, 2025 (view filing)Aug 252 daysKhattar Jack A.President, CEOSSale−1.00K$45.00−$45.0K−0.1%1.07M after10b5-1
Aug 27, 2025 (view filing)Aug 252 daysMottola FrankSVP, Quality, GMP, Ops, ITSSale−14.0K$44.51−$623.1K−47.5%15.5K after
Aug 29, 2025 (view filing)Aug 272 daysNewhall Charles W IIIDirectorSSale−3.59K$45.01−$161.5K−2.7%129.6K after10b5-1
Aug 29, 2025 (view filing)Aug 27-282 daysKhattar Jack A.President, CEOSSale−34.8K$45.10−$1.57M−3.1%1.09M after2 lots10b5-1
Sep 8, 2025 (view filing)Sep 53 daysKhattar Jack A.President, CEOSSale−55.6K$46.01−$2.56M−4.8%1.11M after10b5-1
Sep 9, 2025 (view filing)Sep 81 dayKhattar Jack A.President, CEOSSale−6.32K$46.29−$292.6K−0.6%1.11M after10b5-1
Sep 15, 2025 (view filing)Sep 123 daysMottola FrankSVP, Chief Tech. Ops. OfficerSSale−5.00K$45.87−$229.3K−24.4%15.5K after
Sep 23, 2025 (view filing)Sep 221 dayKhattar Jack A.President, CEOSSale−16.6K$47.02−$779.9K−1.5%1.12M after10b5-1
Sep 24, 2025 (view filing)Sep 231 dayKhattar Jack A.President, CEOSSale−29.5K$47.23−$1.39M−2.5%1.14M after10b5-1
Sep 30, 2025 (view filing)Sep 291 dayKhattar Jack A.President, CEOSSale−10.2K$48.02−$491.5K−0.9%1.14M after10b5-1
Oct 1, 2025 (view filing)Sep 301 dayKhattar Jack A.President, CEOSSale−8.59K$48.25−$414.4K−0.7%1.15M after10b5-1
Oct 2, 2025 (view filing)Oct 11 dayKhattar Jack A.President, CEOSSale−40.2K$48.07−$1.93M−3.3%1.16M after10b5-1
Oct 3, 2025 (view filing)Oct 21 dayKhattar Jack A.President, CEOSSale−1.90K$48.06−$91.5K−0.2%1.16M after10b5-1
Oct 10, 2025 (view filing)Oct 91 dayNewhall Charles W IIIDirectorSSale−25.0K$50.77−$1.27M−19.3%104.6K after2 lots10b5-1
Oct 10, 2025 (view filing)Oct 91 dayKhattar Jack A.President, CEOSSale−59.9K$50.57−$3.03M−4.7%1.21M after2 lots10b5-1
Dec 19, 2025 (view filing)Dec 181 dayBhatt Padmanabh P.Sr. VP of IP, CSOSSale−710$44.44−$31.6K−4.7%14.5K after
Dec 22, 2025 (view filing)Dec 193 daysMottola FrankSVP, Chief Tech. Ops. OfficerSSale−20.0K$50.41−$1.01M−56.3%15.5K after2 lots10b5-1
Feb 23, 2026 (view filing)Feb 194 daysSensenig BethanyDirectorSSale−4.47K$51.01−$228.3K−100.0%0 after2 lots10b5-1
Mar 9, 2026 (view filing)Mar 5-64 daysGemayel GeorgesDirectorSSale−18.8K$53.38−$1.00M−40.8%27.3K after2 lots
Mar 10, 2026 (view filing)Mar 91 dayMottola FrankSVP, Chief Tech. Ops. OfficerSSale−1.62K$53.65−$87.1K−8.1%18.4K after
Mar 10, 2026 (view filing)Mar 9-101 dayHorich William ToddSVP, Commercial OperationsSSale−8.88K$54.50−$483.8K−100.0%0 after2 lots
Mar 16, 2026 (view filing)Mar 124 daysHudson Frederick M.DirectorSSale−5.37K$50.61−$271.7K−8.2%60.4K after
Mar 16, 2026 (view filing)Mar 133 daysKhattar Jack A.President, CEOSSale−35.0K$50.37−$1.76M−3.5%958.1K after3 lots10b5-1
Mar 18, 2026 (view filing)Mar 16-182 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−107.3K$50.24−$5.39M−86.3%17.0K after6 lots10b5-1